Quality of life in hypothyroid subjects treated with levothyroxine: a cross-sectional study
Hamide Rezaeizade, Motahare Shabestari, Narjes Hazar, Akram Ghadiri-Anari, Marjan Mehrali, Mohammad Salehi-Shadkami, Reyhaneh Azizi · 2026
Read Quality of life in hypothyroid subjects treated with levothyroxine: a cross-sectional study by Hamide Rezaeizade, Motahare Shabestari, Narjes Hazar, Akram Ghadiri-Anari, Marjan Mehrali, Mohammad Salehi-Shadkami, Reyhaneh Azizi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13563808.txt.
Description
Hamide Rezaeizade and six colleagues ask a question: if thyroid blood tests are corrected by levothyroxine, why do patients still feel worse than healthy people? Their 2026 cross-sectional study enrolled 220 participants, half of them hypothyroid patients on the replacement drug and half healthy controls, matched in having equivalent hormone levels on paper. Everyone completed the World Health Organization's quality-of-life questionnaire, covering physical health, mental health, social life, and environment.
The treated group scored lower on every subscale, and on quality of life and general health, despite the matched blood work. Regression singled out three predictors of the score: being a patient dragged it down steeply, while education and the active hormone T3 lifted it. The authors conclude that normalising the blood numbers does not restore lived health. They press for care that asks patients how they feel, and for research into the T3 gap.
Catalog record
| CREATOR | Hamide Rezaeizade, Motahare Shabestari, Narjes Hazar, Akram Ghadiri-Anari, Marjan Mehrali, Mohammad Salehi-Shadkami, Reyhaneh Azizi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 25453 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |